Plasma oxytocin, early predictor of transient postoperative arginine vasopressin deficiency
The Journal of Clinical Endocrinology & Metabolism · 18.11.2026 · 111 (12) · 3367-3375
DOI: 10.1210/clinem/dgag270 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 08.07.2026. Verfasst von Paul E Constanthin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals, 1205 Geneva, Switzerland. Hauptthemen laut MEDLINE: Oxytocin, Arginine Vasopressin, Postoperative Complications. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Foundation for medical-biological Research 2024, Fondation Ernst et Lucie Schmidheiny, SwissLife Jubiläumsstiftung für Volksgesundheit und medizinische Forschung 2024.
Abstract (Originalsprache)
Context
Arginine vasopressin deficiency (AVP-D) is a well-known complication of transsphenoidal pituitary surgery (TPS) that is difficult to predict because of the lack of specific biomarkers. Although oxytocin (OXT) and copeptin were previously suggested as possible biomarkers, there is, to date, no study that compared those 2 markers in the prediction of post-TPS AVP-D.
Objectives
To compare plasma OXT and copeptin levels among patients operated by TPS presenting with AVP-D and those remaining normonatremic. To establish OXT and copeptin cutoff values for the prediction of post-TPS AVP-D. Design and Patients Both OXT and copeptin levels in the blood of 74 consecutive patients subjected to TPS were measured. OXT and copeptin values were then compared between patients developing AVP-D and patients remaining normonatremic.
Setting
Neurosurgical department of a university hospital. Main outcome measures Blood levels of copeptin and OXT were measured before, 1 day after, and 3 months after TPS.
Results
Patients developing AVP-D showed significantly lower levels of OXT in blood, both before and immediately after TPS, and significantly lower levels of copeptin only after TPS. We identified a preoperative cutoff value for OXT of 69 pg/mL (sensitivity: 90%; specificity: 66%; area under the curve: 0.76 ± 0.06 [P = .0089]) for the prediction of AVP-D. No such significant cutoff values were identified for preoperative copeptin. Of note, OXT, but not copeptin, levels were still significantly lower at 3 months after TPS in AVP-D patients.
Conclusion
These results show for the first time that OXT is superior to copeptin for the preoperative prediction of postoperative AVP-D, acting as a preoperative marker of posterior “pituitary reserve.”
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals, 1205 Geneva, Switzerland.
- Faculty of Medicine, University of Geneva, 1206 Geneva, Switzerland.
- HUG NeuroCentre, Geneva University Hospitals, 1205 Geneva, Switzerland.
- Department of Nephrology, Geneva University Hospitals, 1205 Geneva, Switzerland.
- Department of Endocrinology, Diabetology, and Metabolism, Geneva University Hospitals, 1205 Geneva, Switzerland.
- Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
ORCID-Profile: Paul E Constanthin, Sophie De Seigneux, Mirjam Christ-Crain, Shahan Momjian
Förderung
- Novartis Foundation for medical-biological Research 2024
- Fondation Ernst et Lucie Schmidheiny
- SwissLife Jubiläumsstiftung für Volksgesundheit und medizinische Forschung 2024
- SwissLife Jubiläumsstiftung für Volksgesundheit und medizinische Forschung 2024
Zitieren
APA
Constanthin, P. E., Isidor, N., De Seigneux, S., Mavromati, M., Christ-Crain, M., Lejri, I., Eckert, A., & Momjian, S. (2026). Plasma oxytocin, early predictor of transient postoperative arginine vasopressin deficiency. The Journal of Clinical Endocrinology & Metabolism, 111(12), 3367-3375. https://doi.org/10.1210/clinem/dgag270
Vancouver
Constanthin PE, Isidor N, De Seigneux S, Mavromati M, Christ-Crain M, Lejri I, et al. Plasma oxytocin, early predictor of transient postoperative arginine vasopressin deficiency. The Journal of Clinical Endocrinology & Metabolism. 2026;111(12):3367-3375. doi:10.1210/clinem/dgag270
BibTeX
@article{Constanthin2026,
author = {Constanthin, Paul E and Isidor, Nathalie and De Seigneux, Sophie and Mavromati, Maria and Christ-Crain, Mirjam and Lejri, Imane and Eckert, Anne and Momjian, Shahan},
title = {Plasma oxytocin, early predictor of transient postoperative arginine vasopressin deficiency},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {12},
pages = {3367--3375},
doi = {10.1210/clinem/dgag270}
}
EUVIMED